Miguel Ángel Muñoz-Alía (@mamdayindayout) 's Twitter Profile
Miguel Ángel Muñoz-Alía

@mamdayindayout

#virology #paramyxoviruses #vaccines

ID: 1570478749

calendar_today05-07-2013 12:50:26

700 Tweet

81 Followers

145 Following

Mayo Clinic (@mayoclinic) 's Twitter Profile Photo

Mayo Clinic scientists conclude in new publication that there is a near-zero probability for the natural emergence of a new measles virus capable of evading vaccine-induced immunity. Read more: mayocl.in/3sHD3UD

Mayo Clinic scientists conclude in new publication that there is a near-zero probability for the natural emergence of a new measles virus capable of evading vaccine-induced immunity. Read more: mayocl.in/3sHD3UD
Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Live-attenuated measles virus (MeV) remains antigenically monotypic. Escape from serum neutralization requires elimination of at least 5 co-dominant antigenic sites in the Hemagglutinin (H)-glycoprotein. Emergence of new serotypes is highly unlikely. Mayo Clinic Miguel Ángel Muñoz-Alía

Bloom Lab (@jbloom_lab) 's Twitter Profile Photo

We've written a perspective on a new study by Miguel Ángel Muñoz-Alía that helps explain why some viruses (measles) don't evolve to escape immunity but others (influenza) do. Provides some clues relevant to future for #SARSCoV2 as well: cell.com/cell-reports-m… Here is a recap: (1/n)

Bloom Lab (@jbloom_lab) 's Twitter Profile Photo

Now Miguel Ángel Muñoz-Alía has completed the picture with a new study in Cell Reports Medicine showing that measles polyclonal antibodies have very broad activity, such that no single (or even double or triple) mutant has much reduction in neutralization (cell.com/cell-reports-m…). (11/n)

Thread Reader App (@threadreaderapp) 's Twitter Profile Photo

Shanmuga_Sozhamannan@AuSpread Hello, please find the unroll here: We've written a perspective on a new study by Miguel Ángel Muñoz-Alía that… threadreaderapp.com/thread/1385664… Share this if you think it's interesting. 🤖

Miguel Ángel Muñoz-Alía (@mamdayindayout) 's Twitter Profile Photo

Absolutely delighted about #TWiV featuring our work on the constraints on measles antigenic evolution. Shout out to Bloom Lab, Cell Reports Medicine and Isabel Goldman for also giving visibility to our work.

Eric Topol (@erictopol) 's Twitter Profile Photo

Not only do we have vaccines that can prevent covid infections from all variants, but we also have monoclonal antibodies that can protect vs/treat all of the variants that have emerged to date cell.com/cell/fulltext/… New Cell

Not only do we have vaccines that can prevent covid infections from all variants, but we also have monoclonal  antibodies that can protect vs/treat all of the variants that have emerged to date cell.com/cell/fulltext/… New <a href="/CellCellPress/">Cell</a>
Eric Topol (@erictopol) 's Twitter Profile Photo

"The fact it has happened twice in 18 months, two lineages (Alpha and then Delta) each 50% more transmissible is a phenomenal amount of change"—Aris Katzourakis bbc.com/news/health-57… by James Gallagher BBC Health News

"The fact it has happened twice in 18 months, two lineages (Alpha and then Delta) each 50% more transmissible is a phenomenal amount of change"—<a href="/ArisKatzourakis/">Aris Katzourakis</a> 
bbc.com/news/health-57… 
by <a href="/JamesTGallagher/">James Gallagher</a> <a href="/bbchealth/">BBC Health News</a>
Eric Topol (@erictopol) 's Twitter Profile Photo

Just published Cell report on the Delta variant's immune evasion property: —Less than Beta (good!) —Vaccines should hold up (as effectiveness data supports) —Prior covid with beta or gamma variants susceptible to reinfection by delta cell.com/cell/fulltext/…

Just published <a href="/CellCellPress/">Cell</a> report on the Delta variant's immune evasion property:
—Less than Beta (good!) 
—Vaccines should hold up (as effectiveness data supports)
—Prior covid with beta or gamma variants susceptible to reinfection by delta
cell.com/cell/fulltext/…
Nir Drayman (@nirdrayman) 's Twitter Profile Photo

*New paper alert* I'm happy to share that our manuscript "Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2" is now published in Science Magazine. you can find it here: science.sciencemag.org/content/early/…. I did a long thread for the preprint a year ago :)

Céline Gounder, MD, ScM, FIDSA 🇺🇦 (@celinegounder) 's Twitter Profile Photo

1/ Here is a comprehensive review of the data on whether we need COVID BOOSTER SHOTS. THE MOST IMPORTANT TAKEAWAY: IF YOU HAVEN'T YET GOTTEN A COVID VACCINE, NOW'S THE TIME! I'll put a Threadreader unroll at the end for those of you who find that more convenient to read/share.

Miguel Ángel Muñoz-Alía (@mamdayindayout) 's Twitter Profile Photo

If you are interested in our efforts on a new measles vaccine for early immunization of infants, stay tuned tomorrow, July 22 at #ASV2021. W36-7 at 3.30pm CT

bioRxiv Microbiology (@biorxiv_micrbio) 's Twitter Profile Photo

Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles ... biorxiv.org/cgi/content/sh… #biorxiv_micrbio

Miguel Ángel Muñoz-Alía (@mamdayindayout) 's Twitter Profile Photo

Exciting news! Our research on "Surface-modified measles vaccines boosting neutralizing antibodies against Omicron and historical variants" is an Editor's Pick! Read it here: mBio journals.asm.org/doi/10.1128/mb… #Vaccines #COVID19 #measles